Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novocure Ltd Ord Sh (NQ: NVCR )

12.99 +0.49 (+3.92%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,608,296
Open 12.50
Bid (Size) 12.83 (1)
Ask (Size) 13.17 (1)
Prev. Close 12.50
Today's Range 12.40 - 13.37
52wk Range 10.87 - 120.03
Shares Outstanding 103,647,871
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FCEL Stock Alert: FuelCell Energy Announces AI Deal With IBM
FuelCell Energy stock is climbing higher on Tuesday as investors in FCEL celebrate the company signing a deal with IBM! 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Novocure Layoffs 2023: What to Know About the Latest NVCR Job Cuts
Novocure layoffs are coming for 13% of the company's workers as it seeks to reduce its headcount by 200 people to reduce costs. 
Via InvestorPlace
Topics Workforce
Exposures Layoff

Performance

YTD
-80.88%
-80.88%
1 Month
+0.85%
+0.85%
3 Month
-39.36%
-39.36%
6 Month
-84.26%
-84.26%
1 Year
-83.35%
-83.35%

More News

Read More
Novocure Announces Portfolio Prioritization and Strategic Restructuring Plan Focused on Near-term Growth Drivers and an Accelerated Path to Profitability
From Novocure
Via Business Wire
Novocure to Participate in 35th Annual Piper Sandler Healthcare Conference
From Novocure
Via Business Wire
Is Novocure Stock a Buy?
Via The Motley Fool
Why Novocure Stock Fell 24.4% This Week
Via The Motley Fool
Novocure Announces Presentations on Tumor Treating Fields Therapy, Including New Clinical Data and Real-World Evidence, at 2023 Society for Neuro-Oncology Annual Meeting
From Novocure
Via Business Wire
Why Novocure Stock Was Sick Today
Via The Motley Fool
NovoCure (NVCR) Q3 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Novocure Reports Third Quarter 2023 Financial Results
From Novocure
Via Business Wire
Novocure Announces Presence at European Society for Medical Oncology (ESMO) Congress 2023
From Novocure
Via Business Wire
Novocure and Stanford School of Medicine to Establish Tumor Treating Fields Research Program
From Novocure
Via Business Wire
NovoCure Limited (NASDAQ:NVCR) Long Term Shareholder Notice: Investigation of Potential Wrongdoing
Via SBWire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Novocure to Report Third Quarter 2023 Financial Results
From Novocure
Via Business Wire
Novocure Announces Presence at American Society for Radiation Oncology (ASTRO) 2023 Annual Meeting
From Novocure
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
3 Things About NovoCure That Smart Investors Know
Via The Motley Fool
Novocure Highlights Use of Tumor Treating Fields Therapy in Treatment of Non-Small Cell Lung Cancer at 2023 World Conference on Lung Cancer
From Novocure
Via Business Wire
3 Healthcare Stocks to Sell in September Before They Crash & Burn
Via InvestorPlace
Down 31% in 1 Day, What's Next for NovoCure Stock?
Via The Motley Fool
Is NovoCure's Stock Headed for a Free Fall?
Via The Motley Fool
Novocure Announces The Lancet Oncology Publishes Primary Data from Phase 3 LUNAR Clinical Trial in Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
From Novocure
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
What's Going On With NovoCure Stock Today?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.